Tubular lesions and tubular cell adhesion molecules for the prognosis of lupus nephritis  by Daniel, Laurent et al.
Kidney International, Vol. 60 (2001), pp. 2215–2221
Tubular lesions and tubular cell adhesion molecules for the
prognosis of lupus nephritis
LAURENT DANIEL, HELENE SICHEZ, ROCH GIORGI, BERTRAND DUSSOL,
DOMINIQUE FIGARELLA-BRANGER, JEAN-FRANC¸OIS PELLISSIER, and YVON BERLAND
Departments of Pathology and Statistics, Timone Hospital, and Department of Nephrology, Conception Hospital,
Marseilles, France
Tubular lesions and tubular cell adhesion molecules for the prog- lar features, is the method generally used to describe
nosis of lupus nephritis. histological lesions in lupus nephritis [2]. Others and we
Background. To assess the prognostic value of tubular le- have shown that tubular lesions determine the prognosissions and cell adhesion molecules’ expression, a retrospective
of numerous glomerulopathies like immunoglobulin Astudy with immunohistochemistry was performed on 152 pa-
(IgA) nephropathy [3, 4], and it is well known that celltients presenting lupus nephritis from January 1985 to Decem-
ber 1999. adhesion molecules play a central role in the pathogene-
Methods. The following clinical parameters were recorded: sis of such tubular lesions [5]. These molecules are in-
age, sex, race, time of systemic lupus erythematosus (SLE) volved in various pathophysiological mechanisms likediagnosis, time of the biopsy, proteinuria, creatininemia, and
initial immune response or binding to extracellular ma-renal function at the end of follow-up. All biopsies were re-
trix. Intracellular adhesion molecule-1 (ICAM-1), a mem-evaluated according to a tubular grading, an inflammatory
grading, the percentage of sclerosed glomeruli, the percentage ber of the immunoglobulin superfamily, and CD40, a
of crescents, and the current WHO classification. Immunohisto- member of the tumor necrosis factor (TNF) receptor
chemistry was performed with anti-CD40, anti-CD44, and anti-
family, favor direct interactions between tubular cellsintercellular adhesion molecule-1 (anti-ICAM-1) antibodies.
and interstitial lymphocytes. CD44 enhances adhesionResults. Patients were 136 women (89.5%) and 16 men with
a mean age of 31.2 years  12.8 at the time of biopsy. The to the extracellular matrix by tubular cells. Its ligands,
mean follow-up period was 94.3 months  64.1. Eighty-eight hyaluronic acid and osteopontin, are highly concentrated
biopsies (58%) showed various degrees of tubular atrophy. in the kidney [6, 7].
Males (P  0.001) and tubular grading (P  0.0001) were
De novo tubular expression of ICAM-1 occurs in vari-linked with renal survival in univariate and multivariate analy-
ous human glomerulopathies including lupus nephritissis. CD40 (P  0.01) and ICAM-1 (P  0.001) tubular expres-
sions were linked with renal survival. ICAM-1 tubular expres- [8, 9]. CD40L levels in the serum of patients with lupus
sion provided additional information for the prognosis of the nephritis are high [10]. Also, it was reported in a mouse
patients with biopsies showing tubular atrophy (P  0.005) or model of SLE that CD44 is neoexpressed on tubularnot (P  0.05).
cells [11].Conclusions. Our study shows that tubular lesions are good
The present study was carried out to evaluate bothindicator of lupus nephritis outcome. Furthermore, tubular
expression of cell adhesion molecules like ICAM-1 and CD40 the prognostic value of tubular lesions in lupus nephritis
also serves to predict the outcome. and whether ICAM-1, CD40, and CD44 tubular neo-
expressions increased this prognostic value. Our study
shows that tubular lesions and ICAM-1 and CD40 ex-
Renal involvement in patients with systemic lupus ery- pressions are good prognostic factors for patients with
thematosus (SLE) is frequent. This involvement usually lupus nephritis.
predicts a poor outcome [1]. The World Health Organi-
zation (WHO) classification, which emphasizes glomeru-
METHODS
Patients and biopsy specimens
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rophy. A total of 152 patients who underwent renal biopsies
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Fig. 1. Tubular grading was scored as shown
for the following tubular lesions. All tubules
were normal and showed a regular basal mem-
brane, that is, grade 0 (A, magnification100).
A focus of tubules had a thickened and wrin-
kled basal membrane, grade 1 (B; 100). A
few tubules were normal within an area with
inflammation and fibrosis, grade 2 (C, 100).
All tubules had irregular and thickened basal
membrane, grade 3 (D,100). Jones staining.
Fig. 2. Immunostaining showing cell adhe-
sion molecule expression by tubular cells.
CD44s was expressed by peritubular capillar-
ies and glomerular capsule (A, magnification
250). An isolated proximal tubule showed a
strong basolateral expression of CD44s (B,
250). CD40 had a mild and focal expression
on tubular cells and endothelial glomerular
cells in a case of class II SLE nephritis (C,
250). CD40 was diffusely expressed with a
strong basolateral staining in all tubules in a
case of class III SLE nephritis (D, 40).
ICAM-1 showed a tubular expression with
basolateral and apical staining (E, 250).
ICAM-1 was strongly expressed by glomeru-
lar cells, lymphocytes, and tubular cells in a
case of class IV SLE nephritis (F, 40).
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A questionnaire was addressed to the nephrologists to plasmic staining. First, before primary antibodies were
added, the slides were preincubated for ten minutes atdetermine the outcome of the patients. Proteinuria was
considered significant if it was over 500 mg/dL. The room temperature with blocking-biotin system (Dako,
Trappes, France). Second, after secondary antibodiesthreshold for chronic renal failure was a creatininemia
over 135 mol/L [13]. Specimens of normal renal tissue were added the slides were incubated for ten minutes
with 3% H2O2 to suppress endogen peroxidase reactiva-were obtained from the forensic department; they were
taken in autopsies for scientific purposes. tion. In all sections, the percentage of immunoreactive
tubules was scored by semiquantitative analysis. LabeledThe biopsy was divided into two parts for light micros-
copy (LM) and direct immunofluorescence (IF). For LM, tubules were expressed as percentage of all biopsy tu-
bules. Membrane staining was considered positive. Thistissue was fixed 12 hours in 2.5% glutaraldehyde, and
2-m thick sections were stained with Gomori’s tri- immunostaining was scored according to four grades as
follows: no reactive tubules (grade 0); less than 10% ofchrome. Sections 0.2-m thick were stained with Jones
silver impregnation. For IF, renal tissue was fixed 24 reactive tubules (grade 1); between 10% and 25% of
reactive tubules (grade 2); more than 25% of reactivehours in Michel liquid [14] before being snap-frozen in
80C isopentane and then stored at 80C until use. tubules (grade 3). All biopsy tubules were counted and
immunohistochemical grading was evaluated with aCryostat 5-m thick sections were reacted with fluores-
cinated rabbit antibodies specific for IgG, IgA, IgM, C1q, strong concordance by two observers (LD, HS).
C3, fibrinogen, and immunoglobulin light chains. These
Statistical analysesantibodies were purchased from Binding System (Bir-
mingham, UK). Correlations were established between clinical data,
creatininemia, and histological parameters by Chi-squaredTo evaluate the tubular lesions, serial sections of the
cortical area except in the subcapsular area were exam- test or Yates modified test if theoretical counts were less
than 5. Relative risk (RR) was calculated with 95% con-ined. We considered as lesions atrophic tubules with
wrinkled basal membrane and/or dilated tubules. These fidence interval (CI) at the end of follow-up for the
patients with end-stage renal failure (ESRF) and thosetwo types of lesions were often associated in the same
specimen. The severity of tubular lesions was semiquan- with chronic renal failure (CRF). Renal survival data
were estimated by the Kaplan-Meier method and com-titatively graded as previously described [4]:
Grade 0. Normal tubules (Fig. 1A). pared using the Log Rank test. P values less than 0.05
were considered significant in univariate analysis. Multi-Grade 1. Tubular lesions involving less than 25% of
the cortical area (Fig. 1B). variate analyses were done by logistic regression and Cox
proportional hazard regression with forward stepping.Grade 2. Tubular lesions involving less than 50% but
more than 25% of the cortical area (Fig. 1C). The threshold for entering or removing variables was
P  0.10. Adjusted odds ratio (OR) was calculated withGrade 3. Diffuse tubular lesions or involving more
than 50% of the cortical area (Fig. 1D). 95% CI. Data were analyzed by BMDP-system 1.1 soft-
ware (Meridian Marketing Group, Sedona, AZ, USA).In addition, interstitial inflammation was semiquanti-
tatively graded on a scale of 0, 1, 2, or 3 with the same
percentages used above for tubular lesions.
RESULTS
PatientsImmunohistochemistry
Immunodetection was performed on 5-m–thick serial The patients included 136 women (89.5%) and 16 men
(10.5%) who had a mean age of 28.1 years  14.2 at thecryostat sections (Cryostat Reichert-Jung 2800E, Leica,
Rueil Malmaison, France). These immunostainings were time of SLE diagnosis. Seventeen patients (11.1%) were
children (under 15 years) with a mean age of 11.4 yearsperformed on 123 initial frozen biopsies.
The antibodies were anti-CD44s (2C5; R&D System, 2.5. The mean age of all patients at the first biopsy was
31 years  12.8. There were 118 Caucasians (78%), 30Abington, UK), anti-CD40 (Immunotech, Marseille,
France), and anti-ICAM-1 (Immunotech). For all anti- North Africans (19.5%), and 4 Asians (2.5%). The mean
delay between the diagnosis of SLE and the first renalbodies, positive controls were frozen human tonsils ob-
tained from autopsies. Negative controls were obtained biopsy was 31.6  52.2 months. Renal involvement was
the first symptom in 41 of the 152 patients (26.9%).by both omitting the primary antibodies and using irrele-
vant immunoglobulins or phosphate-buffered saline Mean creatininemia at the time of biopsy was 116 
88.6 mol/L (median 78 mol/L). At this time, 34 pa-(PBS). After being rinsed, the sections were incubated
for 30 minutes with biotinylated secondary antibodies tients (22.3%) exhibited a renal failure with a mean
creatininemia of 218.3  125.5 mol/L (median 170.5and then visualized by avidin-biotin peroxidase (Kit
Zymed; Clinisciences, Montrouge, France). Two steps mol/L). Mean proteinuria was 3 g/day, and 45.1% of
the patients had a nephrotic syndrome.were of importance to avoid nonspecific tubular cyto-
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Table 1. Univariate analysis: Risk factors for chronic renal failure (CRF) and for end-stage renal failure (ESRF) occurrences
Variables CRF CRF RR 95% CI P ESRF ESRF RR 95% CI P
Tubular grade
0 10 40 1 — 7 43 1 —
1 19 36 1.7 0.9–3.3 10 45 1.3 0.6–3.2
2 9 4 3.5 1.8–6.7 103 4 9 2.2 0.8–6.4 0.5
3 3 0 5 2.9–8.7 0 3 ND ND
CD44
0% 5 26 1 — 5 26 1 —
1–10% 15 37 1.8 0.7–4.5 7 45 0.8 0.3–2.4
11–25% 5 1 5.2 2.2–12.5 0.002 2 4 1.6 0.4–5.8 0.3
	25% 8 3 4.5 1.9–10.9 3 8 1.7 0.5–5.9
CD40
0% 4 25 1 — 3 26 1 —
1–10% 15 29 2.5 0.9–6.7 6 38 1.3 0.4–4.8
11–25% 4 9 2.2 0.7–7.6 0.002 3 10 2.2 0.5–9.6 0.1
	25% 10 4 5.2 2–13.6 5 9 3.4 1–12.4
ICAM-1
0% 0 36 ND ND 0 36 ND ND
1–10% 10 17 ND ND 8 19 ND ND
11–25% 11 6 ND ND 103 3 14 ND ND 103
	25% 12 8 ND ND 6 14 ND ND
Abbreviations are: RR, relative risk; ICAM-1, intercellular adhesion molecule-1; ND, not done (RR could not be calculated because there was no event for IHC
ICAM-1  0%). P is indicated for each group.
Creatininemia was available for 121 patients (79.6%) a basolateral expression in proximal and distal tubules
(Fig. 2B). Most of these tubules were atrophic but thereat the end of follow-up, including 100 patients with frozen
specimens. Two deaths related to the disease occurred were areas of non-stained atrophic tubules. Thirty-six
biopsies (29.3%) showed no tubular staining and onlyduring the follow-up. The mean follow-up period was
94.3  64.1 months. At the end of the follow-up, 41 11 (8.9%) had strong staining. Additionally, glomerular
crescents and interstitial lymphocyte aggregates werepatients (26.9%) had CRF, including 21 (13.8%) with
ESRF. Only 8 of those 21 had initial CRF. Hence, twenty strongly stained by CD44s antibody as previously re-
ported in mouse models [11].patients (13.5%) had CRF at the last consultation, in-
cluding 9 with initial CRF. Seventeen patients with initial For the anti-CD40 antibody, normal kidneys showed
a weak glomerular endothelial cell staining. We observedrenal failure had a normal renal function at the end of
follow-up. The mean age for the patients with CRF was no CD40 expression on distal tubules as previously re-
ported [10]. In SLE renal biopsies, CD40 was expressed43.3  15.3 years and 34.1  13 years for the patients
with ESRF. basolaterally in proximal and distal tubules (Fig. 2C).
Thirty-nine biopsies (31.7%) showed no tubular staining
Renal biopsies and 15 biopsies (12.2%) had strong staining (Fig. 2D).
Additionally, strong glomerular staining was observedAccording to the WHO classification [2], renal biop-
sies showed: 1 (0.7%) WHO class I; 20 (13.1%) WHO in biopsies showing endocapillary proliferation.
For the anti-ICAM-1 antibody, normal kidneys showedclass IIa; 15 (9.8%) WHO class IIb; 44 (28.9%) WHO
class III; 51 (33.5%) WHO class IV; 14 (9.2%) WHO class weak staining of glomeruli and peritubular capillaries. In
SLE renal biopsies, ICAM-1 showed a strong basolateralV; 5 (3.2%) WHO class VI; 1 (0.7%) interstitial nep-
hritis; and 1 (0.7%) thrombotic microangiopathy with and apical expression in atrophic and non-atrophic proxi-
mal and distal tubules (Fig. 2E). Forty-five biopsiesantiphospholipid syndrome. Fifty-nine biopsies (38.8%)
showed crescent formation and sclerosed glomeruli. In- (36.6%) showed no tubular staining, but 23 biopsies
(18.7%) had strong staining (Fig. 2F). Additionally, weterstitial inflammation was absent in 74 biopsies (48.7%),
whereas 58 (38.1%), 19 (12.5%), and 1 (0.7%) had grade observed strong staining in peritubular capillaries and
proliferative glomeruli. Note that at the time of the1, grade 2, and grade 3 tubular lesions, respectively. Tu-
bular atrophy was absent in 64 biopsies (42.1%), whereas biopsy, ICAM-1 immunostaining was linked with both
CD40 immunostaining (P  103) and CD44 immuno-72 (47.3%), 13 (8.6%), and 3 (2%) had grade 1, grade
2, and grade 3 tubular lesions, respectively. staining (P 0.007). Conversely, CD40 immunostaining
was not linked with CD44 immunostaining (P  0.2).
Immunohistochemistry
Clinicopathologic correlationsFor the anti-CD44s antibody, normal kidneys showed
weak staining within the interstitium but not within the At the end of the follow-up, the variables of the univar-
iate analysis linked with ESRF were the following: thetubules (Fig. 2A). In SLE renal biopsies, CD44s showed
Daniel et al: Prognosis of lupus nephritis 2219
Fig. 3. Kaplan-Meier analysis with Log Rank test. (A) Probability of renal survival in patients with tubular atrophy. The patients with biopsies
showing low-grade tubular lesions had a higher renal survival rate (P  104). The renal survival rate was also higher for the patients with biopsies
showing low tubular CD40 expression (B) (P  0.01) and low tubular ICAM-1 expression (C) (P  0.001). This was not found for the tubular
CD44s expression (D) (P  0.2).
initial renal failure (P  0.02), the nephrotic syndrome CRF was linked with both tubular grading and the cell
adhesion molecules expressions. Male sex (P 0.2), race(P  0.01), and the crescent percentage (P  0.03). Ta-
ble 1 shows the results for tubular grading and immuno- (P  0.6), nephrotic syndrome (P  0.1), the crescent
percentage (P 0.1), and the inflammatory grading (Phistochemistry. ICAM-1 tubular expression was linked
with ESRF occurrence (P  103). Age (P  0.7), male 0.1) were not significant.
In the multivariate analysis, the nephrotic syndromesex (P  0.1), race (P  1), inflammatory grading (P 
0.7), and the percentage of sclerosed glomeruli (P 0.6) was the only variable linked with ESRF (adjusted OR
6.5; CI 1.7 to 25.4). Similarly, the percentage of sclerosedwere not significant.
At the end of follow-up, the following variables of the glomeruli was the only variable linked with CRF (ad-
justed OR 1.2; CI 1.1 to 1.25).univariate analysis were linked with CRF: age (P 0.04),
the initial renal failure (P  104), and the percentage Renal survivals were 86.5%  4 and 78%  5 at five
years and ten years follow-up, respectively. Univariateof sclerosed glomeruli (P  0.006). Table 1 shows the
results for tubular grading and immunohistochemistry. analysis of renal survival differed for the men (65 months
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Table 2. Multivariate analysis of renal survival with [3, 16, 17]. Tubular cells can directly interact with in-
Cox regression analysis
flammatory cells by expressing ICAM-1, which allow
Variables RR 95% CI P them to recruit T activated lymphocytes [18, 19]. These
Females 0.1 0.03–0.5 0.001 lymphocytes release interleukin-2 (IL-2), interferon-

Tubular grade 0 1 — — (INF-
), and tumor necrosis factor- (TNF) to activate
Tubular grade 1 1.6 0.4–6.3 103
mononuclear cells and fibroblasts. Finally, ICAM-1 tu-Tubular grade 2 31.2 3.8–256 103
bular expression could lead to interstitial fibrosis [20, 21].
Similar tubular expression of adhesion molecules has
been described in allograft rejection [22]. We think that
ICAM-1 expression should be a useful marker in SLEof mean survival vs. 136; P  0.01), the patients with
renal biopsies, particularly in the WHO class V subgroup.initial CRF (89.7 months of mean survival vs. 141; P 
The CD40/CD40L activation pathway should lead both0.001), and last for patients with nephrotic syndrome
to the induction of the human lymphocyte antigen (HLA)-(120.2 months of mean survival vs. 124.4; P  0.03).
complex by tubular cells as for lymphocytes [23] and toTubular atrophy (Fig. 3A) and immunostainings of CD40
the provision of cytokines and chemokines by mononu-(Fig. 3B) and ICAM-1 (Fig. 3C), but not CD44s (Fig. 3D),
clear cells [24]. The role of CD40/CD40L interactions iswere strongly correlated with renal survival. Race (P 
well established in human renal allograft rejection, par-0.8), inflammatory grading (P  0.9), and WHO classifi-
ticularly in the indirect pathway of allogenic recognitioncation (P  0.5) were not linked with renal survival.
[22]. For lupus nephritis, while Yellin et al showed a roleTable 2 shows the multivariate analysis of renal survival
for this pathway in a series, no follow-up data were in-with Cox’s model. This model highlighted the role of
cluded [10]. Our study observed a prognostic value fortubular lesions to determine the prognosis of renal sur-
CD40 expression. This is in keeping both with high solu-vival. To evaluate the impact of cell adhesion molecules
ble CD40L levels reported in the active forms of SLEimmunostaining better, we performed a Kaplan-Meier
[25] and with the positive effects of anti-CD40L antibodyanalysis with Log Rank test stratified on tubular atrophy.
administration in murine lupus nephritis [26]. Neverthe-This analysis showed that at each stage of tubular atro-
less, the role of CD40/CD40L is more complex becausephy (that is, grades 0, 1, and 2 to 3), the immunostaining
CD40, despite its proinflammatory effects, should be down-profile of ICAM-1 (P  0.05, 0.1, and 0.005) led to
regulated on tubular cells by soluble CD40L in an auto-additional information for the prognosis. These results
crine and paracrine fashion [27]. Furthermore, CD40/were not found for the WHO classification (P  0.3, 0.5,
CD40L stimulation leading to anti-apoptotic mechanisms0.9) or for the inflammatory grading (P  0.8, 0.9, 0.3).
[28] may inhibit the cellular effects of the T cytolytic-
activated lymphocytes within the interstitium. The CD40/
DISCUSSION CD40L pathway also could decrease renal survival because
it plays a role during the evolution of atheroma [29].Our study shows that as in many primary glomerulopa-
thies tubular lesions strongly predict the decline in renal CD44s plays a role both in recruitment of inflamma-
tory cells and in adhesion to extracellular matrix by bind-function in lupus nephritis. Paradoxically, these tubular
lesions are not precisely quantified in the current WHO ing hyaluronic acid (HA), fibronectin, laminin, and colla-
gen [30]. Tubular CD44s expression is enhanced in lupusclassification [2]. The WHO classification alone was not
accurate for predicting the prognosis of SLE nephritis. nephritis mouse model [11, 31]. Similarly, as we have
shown for neoplastic renal cells [32], CD44s could beMore interestingly, we observed that tubular ICAM-1
and CD40 expressions are potential prognostic factors expressed by tubular cells in inflammatory experimental
renal diseases [33] and animal model [34]. If CD44s mole-in the progression of lupus nephritis because they could
predict the outcome of patients with nephritis who ex- cules are aggregated, they could up-regulate ICAM-1
expression [35]. Another potential role of CD44s is thehibit no or slight tubular atrophy. Moreover, ICAM-1
expression was useful even for the patients with biopsies regulation of chemokines [36]. Despite these potential
roles in SLE nephritis, we did not find a clear prognosticshowing fibrous changes and high-grades of tubular atro-
phy. In univariate analysis, ICAM-1 was linked with ESRF value for CD44s expression. This may be explained by
an inappropriate size of HA in vivo, as previously hy-and CRF occurrences. The present data agree with recent
results, which emphasized the predictive power of both pothesized [37]. In conclusion, we show that tubular his-
tological grading is a strong parameter for determiningthe tubulointerstitial activity index on initial biopsies and
the presence of macrophages on control biopsies from the renal outcome for lupus nephritis. Furthermore, we
show that ICAM-1 and perhaps CD40 immunostainingpatients under therapy [15]. These findings suggest that
the tubules play a central role in recruiting macrophages. provide additional information. Patients with biopsies
showing such immunostaining should have a more ag-An increasing amount of data supports that tubular
lesions are predictive of progression in glomerulopathies gressive treatment.
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